53rd EASD Annual Meeting (4)
Lisbon, Portugal, 11-Sep-17
Exenatide Study of Cardiovascular Event Lowering (EXSCEL): primary results
Ray, Prof. K.
Poster Session 101 - Cardiovascular intervention in mice and men - 9 posters
Home, Prof. P.
Role of alirocumab in lipid management of individuals with type 1 and type 2 diabetes at high CV risk: ODYSSEY DM program
Müller-Wieland, Prof. D.
Poster Session 71: SGLT2 inhibitors: glucagon and liver issues
Schernthaner, Prof. G.
J-DOIT3: a multifactorial intervention trial for prevention of macrovascular complications and mortality
Groop, Prof. P.-H.
Supported by Boehringer Ingelheim Pharma GmbH & Co. KG